Literature DB >> 23011320

Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension.

Florian F Hildenbrand1, Konrad E Bloch, Rudolf Speich, Silvia Ulrich.   

Abstract

BACKGROUND: Nocturnal hypoxemia is important in precapillary pulmonary hypertension (pPH) as it worsens pulmonary hemodynamics. Whether daytime oxygen saturation (SpO(2)) predicts nocturnal hypoxemia in pPH patients has not been conclusively studied.
OBJECTIVES: To investigate the prevalence of nocturnal hypoxemia in comparison to daytime SpO(2) and disease severity in ambulatory patients with pulmonary hypertension.
METHODS: Consecutive patients diagnosed with pPH classified as either pulmonary arterial (PAH) or chronic thromboembolic pPH (CTEPH) had daytime resting and exercise SpO(2) (at the end of a 6-min walk test); thereafter, they underwent overnight pulse oximetry at home. Functional class, pro-brain natriuretic peptide (pro-BNP) and the tricuspid pressure gradient were assessed.
RESULTS: Sixty-three patients [median (quartiles) age 62 (53; 71), 43 females] with PAH (n = 44) and CTEPH (n = 19) were included. The resting SpO(2), exercise SpO(2), and mean nocturnal SpO(2) were 95% (92; 96), 88% (81; 95), and 89% (85; 92), respectively. Forty-nine patients (77%) spent >10% of the night with SpO(2) <90% (desaturators), and 33 (52%) spent >50% of the night with SpO(2) <90% (sustained desaturators). The positive predictive values of daytime SpO(2) >90% for being a nocturnal nondesaturator or sustained nondesaturator were 25 and 53%, respectively. Nocturnal SpO(2) was negatively correlated with the tricuspid pressure gradient, but not with functional class, 6-min walk test, or pro-BNP.
CONCLUSIONS: Nocturnal hypoxemia is very common in PAH and CTEPH despite often normal daytime SpO(2) and reflects disease severity. Nocturnal pulse oximetry should be considered in the routine evaluation of pPH patients and research should be directed toward the treatment of nocturnal desaturation in pPH.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23011320     DOI: 10.1159/000341182

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  9 in total

Review 1.  "Nocturnal seizures" in idiopathic pulmonary arterial hypertension.

Authors:  Anthony Izzo; Julia McSweeney; Thomas Kulik; Umakanth Khatwa; Sanjeev V Kothare
Journal:  J Clin Sleep Med       Date:  2013-10-15       Impact factor: 4.062

2.  Effects of exercise and vasodilators on cerebral tissue oxygenation in pulmonary hypertension.

Authors:  Séverine Müller-Mottet; Florian F Hildenbrand; Stephan Keusch; Elisabeth Hasler; Marco Maggiorini; Rudolf Speich; Konrad E Bloch; Silvia Ulrich
Journal:  Lung       Date:  2014-11-21       Impact factor: 2.584

3.  [Pulmonary hypertension: Possible genetic causes and therapeutic options].

Authors:  E Grünig; C A Eichstaedt; N Ehlken; E Mayer; H Klose
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 4.  Regulation and interactions in the activation of cell-associated plasminogen.

Authors:  H Myöhänen; A Vaheri
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

5.  Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia.

Authors:  Marcia S Murta; Ricardo L M Duarte; Daniel Waetge; David Gozal; Alexandre P Cardoso; Fernanda C Q Mello
Journal:  Lung       Date:  2022-06-18       Impact factor: 3.777

6.  Nocturnal hypoxia in patients with idiopathic pulmonary arterial hypertension.

Authors:  Lu Yan; Qin Luo; Zhihui Zhao; Qing Zhao; Qi Jin; Yi Zhang; Zhihong Liu
Journal:  Pulm Circ       Date:  2020-08-21       Impact factor: 3.017

7.  Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study.

Authors:  Etienne-Marie Jutant; David Montani; Caroline Sattler; Sven Günther; Olivier Sitbon; Gilles Garcia; Isabelle Arnulf; Marc Humbert; Thomas Similowski; Stefania Redolfi
Journal:  Pulm Circ       Date:  2021-03-30       Impact factor: 3.017

8.  The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea.

Authors:  Lu Yan; Zhihui Zhao; Qing Zhao; Qi Jin; Yi Zhang; Xin Li; Anqi Duan; Qin Luo; Zhihong Liu
Journal:  BMC Pulm Med       Date:  2021-11-21       Impact factor: 3.317

9.  Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension.

Authors:  Manuel Jonas Richter; Katrin Milger; Khodr Tello; Philipp Stille; Werner Seeger; Eckhard Mayer; Hossein A Ghofrani; Henning Gall
Journal:  BMC Pulm Med       Date:  2016-07-04       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.